Gradient Dissent: Conversations on AI cover image

Matthew Davis — Bringing Genetic Insights to Everyone

Gradient Dissent: Conversations on AI

00:00

Genetic Diagnostics and Breast Cancer

The company itself is about a decade old and it's not a coincidence because the availability of high throughput low cost genome sequencing really came online in 2008. And at that point it became clear that instead of analyzing one or two genes at a time you could be analyzing lots of genes for less money. The strategy that was clear to the founders was here's a market that's a very narrow market with a very high margin but there should be an adjustable market of everyone with access to modern medicine.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app